Returning to Workplaces Safely

How Modeling COVID-19 Testing Can Help Employers Make Informed Decisions

WHITE PAPER
March 12, 2021
Senior Vice President, CVS Health and Chief Medical Officer, CVS Caremark
Senior Director, Data Science, CVS Health
Senior Director, Clinical Trial Analytics, CVS Health
Senior Medical Director, Medical Affairs, CVS Caremark
Lead Data Scientist, COVID Data and Modeling Center, CVS Health

Our latest white paper evaluates the relationship between diagnostic testing and infection control in a range of workplace scenarios. It is based on model simulations of realistic conditions and variables such as cohort size, the fraction of time spent at work, team networks and infection rates inside and outside the workplace.

While vaccine availability continues to improve, strategic COVID-19 testing will remain essential for employers to allow people to return to workplaces safely.

For more information on Return Ready, visit https://cvshealth.com/covid-19/return-ready/workplaces.

WHITE PAPER
March 12, 2021
Senior Vice President, CVS Health and Chief Medical Officer, CVS Caremark
Senior Director, Data Science, CVS Health
Senior Director, Clinical Trial Analytics, CVS Health
Senior Medical Director, Medical Affairs, CVS Caremark
Lead Data Scientist, COVID Data and Modeling Center, CVS Health